Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 Jan;40(1):82-92.
doi: 10.1016/j.jemermed.2010.05.009. Epub 2010 Jun 25.

Thrombolytic therapy for acute ischemic stroke beyond three hours

Christopher R Carpenter  1 , Samuel M Keim, William Kenneth Milne, William J Meurer, William G Barsan; Best Evidence in Emergency Medicine Investigator Group
Affiliations
Meta-Analysis

Thrombolytic therapy for acute ischemic stroke beyond three hours

Christopher R Carpenter et al. J Emerg Med. 2011 Jan.

Abstract

Background: Ischemic cerebrovascular accidents remain a leading cause of morbidity and mortality. Thrombolytic therapy for acute ischemic stroke within 3h of symptom onset of highly select patients has been advocated by some groups since 1995, but trials have yielded inconsistent outcomes. One recent trial demonstrated significant improvement when the therapeutic window was extended to 4.5h.

Clinical question: Does the intravenous systemic administration of tPA within 4.5h to select patients with acute ischemic stroke improve functional outcomes?

Evidence review: All randomized controlled trials enrolling patients within 4.5h were identified, in addition to a meta-analysis of these trial data.

Results: The National Institute of Neurological Disorders and Stroke (NINDS) and European Cooperative Acute Stroke Study III (ECASS III) clinical trials demonstrated significantly improved outcomes at 3 months, with increased rates of intracranial hemorrhage, whereas ECASS II and the Acute Noninterventional Therapy in Ischemic Stroke (ATLANTIS) study showed increased hemorrhagic complications without improving outcomes. Meta-analysis of trial data from all ECASS trials, NINDS, and ATLANTIS suggest that thrombolysis within 4.5h improves functional outcomes.

Conclusion: Ischemic stroke tPA treatment within 4.5h seems to improve functional outcomes and increases symptomatic intracranial hemorrhage rates without significantly increasing mortality.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Evidence-based medicine teaching points.
See this image and copyright information in PMC

References

    1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7. - PubMed
    1. American Heart Association in Collaboration with the International Liason Committee on Resuscitation Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 7: the era of reperfusion: section 2: acute stroke. Circulation. 2000;102(8 Suppl):1204–16. - PubMed
    1. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275–82. - PubMed
    1. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29. - PubMed
    1. Hemphill JC, White DB. Clinical nihilism in neuroemergencies. Emerg Med Clin North Am. 2009;27:27–37. - PMC - PubMed

Substances